Merck Will Pay Up to $2 Billion for Chinese Heart Drug
Merck & Co. will pay as much as $2 billion for the rights to Jiangsu Hengrui Pharmaceuticals Co.’s experimental heart drug, ...
Merck buys rights to heart disease drug in latest China deal
Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...